List of Figures
List of Figures

  • Figure 1. Distribution of zinc ionic species in the Zn2+ and gluconic acid system
  • Figure 2. Effect of different half-lives on percent of patients with symptoms on various days, showing weighted average durations
  • Figure 3. Duration of common colds in ZIA 100 zinc gluconate- and placebo-treated groups
  • Figure 4. Average total severity of colds in ZIA 100 zinc gluconate- and placebo-treated groups
  • Figure 5. Daily clinical score of ZIA 43.9 zinc gluconate- and placebo-treated groups
  • Figure 6. Daily nasal secretion weights in grams for ZIA 44 zinc gluconate- and placebo- treated groups
  • Figure 7. Duration of common colds using bitter ZIA 25 zinc gluconate and placebo
  • Figure 8. Effect of very low dosage ZIA 13.4 zinc gluconate and placebo
  • Figure 9. Effect of ZIA 0 zinc orotate and placebo lozenges and zinc gluconate nasal spray
  • Figure 10. Estimated effect of ZIA 0 zinc aspartate and placebo lozenges
  • Figure 11. Mole fraction Zn2+ species versus pH for solution with Zn2+ and excess citric acid (H3L)
  • Figure 12. Mole fraction for equimolar zinc and citric acid at 10 mMol
  • Figure 13. Estimated effect of ZIA -12.5 zinc gluconate-citrate and placebo lozenges
  • Figure 14. Estimated effect of ZIA -54 zinc acetate- tartarate-carbonate lozenges and placebo
  • Figure 15. Letter from R. J. E. Williams showing procedure and method for producing effervescence in zinc acetate lozenges
  • Figure 16. Estimated effect of zinc gluconate-glycine and placebo on duration of colds
  • Figure 17. Effect of pretreatment cold duration for zinc gluconate-glycine treated sub-groups
  • Figure 18. Concentration of Zn2+, and various zinc glycinate and zinc hydroxide species in the zinc gluconate-glycinate system
  • Figure 19. Relationship of zinc ion availability (ZIA) values and reduction in duration of common colds
  • Figure 20. Concentration of Zn2+ ion in the zinc and acetate system by pH
  • Figure 21. Effect of compressive force upon dissolution times
  • Figure 22. Effect of compressive force upon ZIA values
  • Figure 23. Effect of zinc content on ZIA and Zn2+ mMol concentration
  • Figure 24. Relationship of lozenge zinc content to saliva production.
  • Figure 25. Relationship of lozenge zinc content to lozenge dissolution rate
  • Figure 26. Effect of force applied to lozenge thickness
  • Figure 27. Expected effect of ZIA 100 and ZIA 400 lozenges


    List of Tables